These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Problems of psychotropic drugs in psychopharmacotherapy]. Kashiwase H Yakubutsu Seishin Kodo; 1981 Oct; 1(1):59-68. PubMed ID: 7187792 [TBL] [Abstract][Full Text] [Related]
23. Depression and chronic fatigue. Indications for psychiatric consultation. Hale M; Matthews DA Prim Care; 1991 Jun; 18(2):435-49. PubMed ID: 1876623 [TBL] [Abstract][Full Text] [Related]
25. Role of pivagabine in the treatment of climacteric syndrome. Gigliotti B; Multinu A; Lai VR Arzneimittelforschung; 1997 Nov; 47(11A):1317-21. PubMed ID: 9450156 [TBL] [Abstract][Full Text] [Related]
26. Frequency, timing, and course of depressive symptomatology after whiplash. Carroll LJ; Cassidy JD; Côté P Spine (Phila Pa 1976); 2006 Jul; 31(16):E551-6. PubMed ID: 16845342 [TBL] [Abstract][Full Text] [Related]
28. Depressive symptoms: associations with health perceptions and health behaviors. Lynch D; Tamburrino M; Nagel R Depression; 1996; 4(2):68-72. PubMed ID: 9160643 [TBL] [Abstract][Full Text] [Related]
29. Psychotropic discontinuation symptoms: a case of withdrawal neuroleptic malignant syndrome. Stonecipher A; Galang R; Black J Gen Hosp Psychiatry; 2006; 28(6):541-3. PubMed ID: 17088172 [TBL] [Abstract][Full Text] [Related]
30. Switch from depression to mania, or from mania to depression: role of psychotropic drugs. Angst J Psychopharmacol Bull; 1987; 23(1):66-7. PubMed ID: 3602331 [No Abstract] [Full Text] [Related]
31. Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy. Capuron L; Ravaud A; Miller AH; Dantzer R Brain Behav Immun; 2004 May; 18(3):205-13. PubMed ID: 15050647 [TBL] [Abstract][Full Text] [Related]
32. Update on drug-induced depression in the elderly. Kotlyar M; Dysken M; Adson DE Am J Geriatr Pharmacother; 2005 Dec; 3(4):288-300. PubMed ID: 16503326 [TBL] [Abstract][Full Text] [Related]
33. [Prevalence of depressive symptoms in a population of ambulatory schizophrenics]. Lempérière T; Rodière C; Rousselet N; Pilate C; Ades J; Lépine JP; Rouillon F Ann Med Psychol (Paris); 1983 Feb; 141(2):224-36. PubMed ID: 6137178 [No Abstract] [Full Text] [Related]
34. [Diagnosis of complications of psychopharmacotherapy caused by drug allergy using the vesiculation test]. Zikevskaia KK; Kasatkina GV; Pecherskiĭ VI Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(5):739-43. PubMed ID: 6380168 [TBL] [Abstract][Full Text] [Related]
35. Twelve-month course of depressive symptoms in older medical inpatients. McCusker J; Cole M; Ciampi A; Latimer E; Windholz S; Elie M; Belzile E Int J Geriatr Psychiatry; 2007 May; 22(5):411-7. PubMed ID: 17096457 [TBL] [Abstract][Full Text] [Related]
36. [Effect of psychopharmacotherapy on the course of forced insulin-coma treatment of patients with paranoid schizophrenia]. Skatkin AL Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(12):1836-9. PubMed ID: 3447400 [TBL] [Abstract][Full Text] [Related]
37. Psychotropic drug use and cognitive decline among older men and women. Dealberto MJ; Mcavay GJ; Seeman T; Berkman L Int J Geriatr Psychiatry; 1997 May; 12(5):567-74. PubMed ID: 9193967 [TBL] [Abstract][Full Text] [Related]
38. [Pro and contra: psychotherapy and psychopharmacotherapy attitude of the public]. Angermeyer MC; Held T; Görtler D Psychother Psychosom Med Psychol; 1993 Aug; 43(8):286-92. PubMed ID: 8378520 [TBL] [Abstract][Full Text] [Related]